Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Oyster Point Pharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
OYST is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 53
- −5 vs. Q3 2022
- Shares held
- 17.0M
- −3.06M (−15.3%) vs. Q3 2022
- Total value
- $189.4M
- +$76.9M (+68.4%) vs. Q3 2022
- New holders
- 18
- 12 more added
- Sold out
- 23
- 13 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OYST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $11 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $11 |
| Q3 2025 | 1 | $11 |
| Q2 2025 | 1 | $11 |
| Q1 2025 | 1 | $11 |
| Q4 2024 | 1 | $11 |
| Q3 2024 | 1 | $11 |
| Q2 2024 | 1 | $11 |
| Q1 2024 | 1 | $11 |
| Q4 2023 | 1 | $11 |
| Q3 2023 | 1 | $11 |
| Q2 2023 | 1 | $11 |
| Q1 2023 | 1 | $11 |
| Q4 2022 | 53 | $189.4M |
| Q3 2022 | 60 | $112.6M |
| Q2 2022 | 61 | $87.6M |
| Q1 2022 | 72 | $246.2M |
| Q4 2021 | 80 | $378.8M |
| Q3 2021 | 69 | $210.8M |
| Q2 2021 | 58 | $318.3M |
| Q1 2021 | 61 | $335.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Oyster Point Pharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 5,925,287 | $66.2M | 3.72% | 00.0% | Unchanged |
| Invus Financial Advisors, LLC | 2,768,586 | $30.9M | 16.46% | 00.0% | Unchanged |
| RTW Investments, LP | 2,304,977 | $25.7M | 0.53% | +260,665+12.8% | Added |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $11.6M | 0.39% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 655,044 | $7.32M | 0.21% | +655,044 | New |
| Gabelli Funds LLC | 651,051 | $7.27M | 0.06% | +651,051 | New |
| GW&K Investment Management, LLC | 554,288 | $6.19M | 0.06% | −10,568−1.9% | Reduced |
| MMCAP International Inc. SPC | 515,491 | $5.76M | 0.58% | +515,491 | New |
| Man Group plc | 319,524 | $3.57M | 0.01% | +319,524 | New |
| Jane Street Group, LLC | 221,476 | $2.47M | 0.00% | +202,609+1,073.9% | Added |
| Chicago Capital Management, LLC | 212,234 | $2.37M | 2.15% | +212,234 | New |
| Laurion Capital Management LP | 210,200 | $2.35M | 0.07% | 00.0% | Unchanged |
| Millennium Management LLC | 206,254 | $2.30M | 0.00% | +99,703+93.6% | Added |
| Yakira Capital Management, Inc. | 174,763 | $1.95M | 0.40% | +174,763 | New |
| Gabelli & Co Investment Advisers, Inc. | 170,250 | $1.90M | 0.41% | +170,250 | New |
| Deltec Asset Management LLC | 162,042 | $1.81M | 0.52% | +162,042 | New |
| Gamco Investors, Inc. Et Al | 158,815 | $1.77M | 0.02% | +158,815 | New |
| Susquehanna International Group, LLP | 108,443 | $1.21M | 0.00% | +86,256+388.8% | Added |
| Creative Planning | 107,662 | $1.20M | 0.00% | +1,000+0.9% | Added |
| Bluefin Capital Management, LLC | 45,000 | $502.6K | 0.09% | +45,000 | New |
| Prelude Capital Management, LLC | 44,115 | $492.8K | 0.03% | +44,115 | New |
| Bridgeway Capital Management, LLC | 40,000 | $446.8K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 39,501 | $441.2K | 0.00% | +4,444+12.7% | Added |
| Wildcat Capital Management, LLC | 36,847 | $411.6K | 0.16% | 00.0% | Unchanged |
| Citadel Advisors LLC | 29,511 | $329.6K | 0.00% | −266,547−90.0% | Reduced |
| JPMorgan Chase & Co | 25,532 | $285.0K | 0.00% | +23,817+1,388.7% | Added |
| HRT Financial LP | 24,900 | $278.0K | 0.00% | −17,017−40.6% | Reduced |
| Endurant Capital Management LP | 19,927 | $222.6K | 0.09% | +19,927 | New |
| Citigroup Inc | 18,878 | $210.9K | 0.00% | +18,564+5,912.1% | Added |
| Goldman Sachs Group Inc | 18,261 | $204.0K | 0.00% | −77,425−80.9% | Reduced |
| Equitec Proprietary Markets, LLC | 17,266 | $192.9K | 0.11% | +17,266 | New |
| UBS Group AG | 15,787 | $176.3K | 0.00% | +13,123+492.6% | Added |
| Geode Capital Management, LLC | 14,178 | $158.0K | 0.00% | −140,993−90.9% | Reduced |
| Vanguard Group Inc | 13,500 | $150.8K | 0.00% | −413,595−96.8% | Reduced |
| Guggenheim Capital LLC | 12,816 | $143.2K | 0.00% | +12,816 | New |
| Coastal Bridge Advisors, LLC | 11,970 | $133.7K | 0.04% | 00.0% | Unchanged |
| Crystalline Management Inc. | 11,421 | $127.6K | 0.06% | +11,421 | New |
| Squarepoint Ops LLC | 11,375 | $127.1K | 0.00% | +11,375 | New |
| Bank of America Corp | 11,057 | $123.5K | 0.00% | −2,394−17.8% | Reduced |
| Tower Research Capital LLC (TRC) | 8,861 | $99.0K | 0.00% | −32,050−78.3% | Reduced |
| Morgan Stanley | 7,986 | $89.2K | 0.00% | −136,542−94.5% | Reduced |
| Royal Bank of Canada | 2,997 | $34.0K | 0.00% | −82−2.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,250 | $25.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,085 | $23.3K | 0.00% | −502,288−99.6% | Reduced |
| Freedom Wealth Alliance, LLC | 1,921 | $21.5K | 0.03% | +1,921 | New |
| Group One Trading, L.P. | 1,035 | $11.6K | 0.00% | −334−24.4% | Reduced |
| Huntington National Bank | 896 | $10.0K | 0.00% | +83+10.2% | Added |
| Simplex Trading, LLC | 500 | $5.00K | 0.00% | −4,733−90.4% | Reduced |
| FMR LLC | 342 | $3.82K | 0.00% | +49+16.7% | Added |
| Geneos Wealth Management Inc. | 200 | $2.23K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 106 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 115 | $1.28K | 0.00% | +3+2.7% | Added |
| Belpointe Asset Management LLC | 10 | $112 | 0.00% | +10 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,805,387−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,648,316−100.0% | Sold out |
| Telemark Asset Management, LLC | 0 | $0 | 0.00% | −777,026−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −509,794−100.0% | Sold out |
| KPCB XIV Associates, LLC | 0 | $0 | 0.00% | −367,987−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −77,427−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −48,934−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −20,182−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,172−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,248−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −12,560−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,834−100.0% | Sold out |
| Cherry Creek Investment Advisors, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,761−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −2,052−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,697−100.0% | Sold out |
| Gibson Wealth Advisors LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| ACG Wealth | – | – | – | – | Not filed |
| ACT Capital Management, LLC | – | – | – | – | Not filed |